Brensocatib, sold under the brand name Brinsupri, is a medication used for the treatment of bronchiectasis.

It is a dipeptidyl peptidase 1 inhibitor.

It is taken by mouth.

Brensocatib is indicated for the treatment of non-cystic fibrosis bronchiectasis in people aged twelve years of age and older.